Bundibugyo Virus Disease Cases Rise in Congo and Uganda
Health authorities reported 390 additional suspected cases and 92 deaths in the Democratic Republic of the Congo since 18 May 2026. Laboratory-confirmed cases increased by 72, reaching 105 total, while confirmed deaths rose from four to 10.
app.buzzsumo.comThe Bundibugyo virus disease outbreak in the Democratic Republic of the Congo and Uganda continues to expand, according to a situation report covering data through 24 May 2026. Since the previous update on 18 May, the Democratic Republic of the Congo recorded 390 new suspected cases and 92 deaths.
Laboratory testing confirmed 72 additional cases, bringing the total to 105, and confirmed deaths increased from four to 10. The report notes that these figures require caution because of delays in laboratory testing and confirmation. The outbreak now affects 13 health zones across three provinces.
Miti-Murhesa Health Zone in South Kivu Province reported its first confirmed case during the period.
Officials stated that evidence points to ongoing cross-border transmission between the Democratic Republic of the Congo and Uganda. The geographic spread has increased since the prior update. The situation report covers weekly external surveillance data collected through 24 May 2026.
Key Facts
Story Timeline
2 events- 18 May 2026
Previous situation report recorded 33 confirmed cases and four confirmed deaths in the Democratic Republic of the Congo.
1 source@WHO - 24 May 2026
Updated report shows 105 confirmed cases, 10 confirmed deaths, and 390 additional suspected cases.
1 source@WHO
Potential Impact
- 01
Health facilities in affected zones may face increased demand for testing and isolation capacity.
- 02
Cross-border surveillance between the Democratic Republic of the Congo and Uganda could be expanded.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.